NFKB1 and cancer: In line with the pathways identified by network analysis in Figures 2C,E,F, we verified that treatment with P3F-C2C12-derived exosomes leads to increased phosphorylation (and therefore activation) of ERK and 4-EBP1 (Figure 4A), which are essential mediators of cancer cell survival and proliferation (35, 36).